• Most Popular
  • Most Shared

Barr Pharma Subsidiary PLIVA Receives Approval for Generic ZITHROMAX(R) IV, 500 mg Vial

Tue Jan 23, 2007 4:29am EST
Co announces that PLIVA has rec'd final approval from the F.D.A for its Abbreviated New Drug Application to manufacture and market Azithromycin for Injection, 500 mg vial, the generic version of Pfizer Labs' ZITHROMAX IV. Co intends to launch its product during 1Q07. The co's Azithromycin for Injection, 500 mg vial will compete in a mkt that had total U.S. sales of approx $75 mln, based on I.M.S data for the 12-month period ending Nov 2006.


More from Reuters

Photo

Investors seen jumping the gun on airport security

BANGALORE (Reuters) - Investors' optimism surrounding the shares of airport security systems makers could be premature as interest in the companies' products after the Christmas Day plane scare is not expected to translate into immediate orders.

» More Top News
A hiring sign hangs in a window at PETCO in Falls Church, Virginia June 5, 2009.REUTERS/Kevin Lamarque

Dust off your resumes

Employers say they'll be adding headcount in the coming year. Here's where the jobs will be.  Full Article 

ECONOMY
Tiger Woods blows on his putter on the 10th hole during final round play of the Tournament Players Championship golf tournament at the TPC at Sawgrass in Ponte Vedra, Florida May 13, 2007.

Tiger's $12 billion scandal?

Shareholders of Tiger Woods' sponsors discover that along with the upside, there are big downside risks, too, a study shows.  Full Article 

Sports